Skip to content
Altius – Lifestyle
Author:
AbbVie
AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR® (cariprazine) at Psych Congress 2026
September 18, 2026
AbbVie to Present Phase 3 Etentamig Results and Data from Broad Multiple Myeloma Portfolio at the 2026 International Myeloma Society (IMS) Meeting
September 17, 2026
Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications
September 17, 2026
AbbVie Named Official Pharmaceutical Sponsor of the PGA TOUR and 2026 Presidents Cup, Launches Birdies for Brain Health Campaign
September 15, 2026
Allergan Aesthetics to Advance Scientific Dialogue on Skin Longevity, Aging Biology and Exosome Science at the 2026 Science of Skin Summit
September 15, 2026
AbbVie Declares Quarterly Dividend
September 10, 2026
AbbVie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine
September 10, 2026
AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma
September 3, 2026
AbbVie Completes Acquisition of Apogee Therapeutics
September 3, 2026
AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
September 3, 2026
1
2
3
4
Next Page
→